Indofarma Tbk Capital Reinvestment Ratio
Indofarma Tbk capital reinvestment ratio. Indofarma Tbk (INAF) has a Capital Reinvestment Ratio of 0.00x as of December 2024, meaning it reinvests 0% of its operating cash flow (Rp34.01 Billion) in capital expenditures (Rp6.94 Million). Check INAF total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Indofarma Tbk (2000–2021)
Capital reinvestment ratio of Indofarma Tbk from 2000 to 2021. This chart tracks Indofarma Tbk's Capital Reinvestment Ratio across 14 annual periods. Also explore INAF net asset momentum to track the company's year-over-year net asset growth rate.
Indofarma Tbk Capital Reinvestment Ratio by Year (2000–2021)
Indofarma Tbk capital reinvestment ratio by year from 2000 to 2021. For the full cash flow conversion analysis, see INAF cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (IDR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2021 | 0.23x | Rp92.90 Billion | Rp21.40 Billion | ▼ -22.2% |
| 2020 | 0.30x | Rp46.55 Billion | Rp13.78 Billion | ▲ +137.0% |
| 2019 | 0.12x | Rp20.79 Billion | Rp2.60 Billion | ▼ -80.6% |
| 2017 | 0.64x | Rp147.18 Billion | Rp94.87 Billion | ▲ +277.1% |
| 2015 | 0.17x | Rp134.28 Billion | Rp22.95 Billion | ▼ -54.6% |
| 2014 | 0.38x | Rp148.73 Billion | Rp56.05 Billion | ▲ +140.7% |
| 2011 | 0.16x | Rp29.40 Billion | Rp4.60 Billion | ▼ -33.3% |
| 2010 | 0.23x | Rp23.71 Billion | Rp5.57 Billion | ▼ -56.0% |
| 2009 | 0.53x | Rp40.56 Billion | Rp21.65 Billion | ▲ +1507.3% |
| 2007 | 0.03x | Rp83.42 Billion | Rp2.77 Billion | ▲ +44.4% |
| 2006 | 0.02x | Rp73.15 Billion | Rp1.68 Billion | ▲ +470.4% |
| 2004 | 0.00x | Rp159.25 Billion | Rp642.02 Million | ▼ -98.0% |
| 2003 | 0.21x | Rp40.70 Billion | Rp8.36 Billion | ▼ -89.2% |
| 2000 | 1.90x | Rp27.05 Billion | Rp51.43 Billion | — |